This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Wei Luo - Innovator in Vaccine Adjuvant Technology
Introduction
Wei Luo is an accomplished inventor based in Redwood City, CA. He has made significant contributions to the field of vaccine development, particularly through his innovative work on nanoparticle vaccine adjuvants. His research focuses on enhancing the efficacy of vaccines, which is crucial in the fight against various diseases.
Latest Patents
Wei Luo holds a patent for a "Toll-like receptor agonist-nanoparticle vaccine adjuvant." This patent encompasses compositions and methods related to TLR agonist nanoparticle vaccine adjuvant formulations. His work in this area aims to improve vaccine responses and overall effectiveness.
Career Highlights
Wei Luo is affiliated with Leland Stanford Junior University, where he engages in cutting-edge research. His position at this prestigious institution allows him to collaborate with other leading scientists and contribute to advancements in immunology and vaccine technology.
Collaborations
Wei has worked alongside notable colleagues, including Qian Yin and Mark M. Davis. These collaborations have further enriched his research and have led to significant advancements in the field.
Conclusion
Wei Luo's innovative work in vaccine adjuvant technology highlights his commitment to improving public health through scientific research. His contributions are paving the way for more effective vaccines in the future.